Status:
COMPLETED
Optimizing the Consent Process for Emergent Laparoscopic Cholecystectomy
Lead Sponsor:
Dr. Boris Zevin
Conditions:
Consent
Laparoscopic
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
The Canadian Medical Protective Association (CMPA) defines informed consent (IC) as a voluntary process where important elements include details of the procedure, complications, and proposed alternati...
Detailed Description
Required elements for an informed consent (IC) in surgery have been well established. The Canadian Medical Protective Association (CMPA) defines IC as a voluntary process where important elements incl...
Eligibility Criteria
Inclusion
- Must be 18 years of age or older
- Individuals admitted to Kingston Health Sciences Centre with acute cholecystitis
- Must be able to read, write and speak English
- Must be able to provide consent
Exclusion
- Individuals who are not able to provide informed consent for laparoscopic cholecystectomy.
- Individuals who are not able to access and view the interactive digital education platform
- Individuals who can not read, write or speak English
Key Trial Info
Start Date :
September 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT04852016
Start Date
September 21 2021
End Date
September 30 2023
Last Update
April 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen's University
Kingston, Ontario, Canada, K7L4V1